4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-25-000228
Director sold 2,750 shares at an average $85.17 ($234,217)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FOLETTA MARK G Director | 2025-07-15 | Sale 10b5-1 | −2,742 | $85.17 | $233,528 | 53,879 | I: show line 1 in the form |
| FOLETTA MARK G Director | 2025-07-15 | Sale 10b5-1 | −8 | $86.03 | $688 | 53,871 | I: show line 2 in the form |
| Open-market sales · 2,750 sh · avg $85.17 · $234,217 | |||||||
Loading xslF345X05/wk-form4_1752782910.xml…